background image

Paid Clinical Trials Iowa City

Discover 508 paid clinical trials in Iowa City, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & ResponsiveNew

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

for
Acute Biphenotypic Leukemia, Acute Leukemia,
Location: Iowa City IA, Cleveland OH, Pittsburgh PA,
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 26

Code: NCT03779854

Phase2, Recruiting
Active & ResponsiveNew

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

for
Primary Sclerosing Cholangitis (PSC)
Location: Iowa City IA, Nashville TN, Baltimore MD, Seattle WA
Sponsor: LISCure Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06699121

Phase2, Recruiting
Active & Responsive

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Iowa City IA, Nashville TN, Hamilton, Ottawa,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting
Active & Responsive

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

for
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor,
Location: Iowa City IA, Chicago IL, Ann Arbor MI, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12+

Code: NCT04924075

Phase2, Recruiting
Active & Responsive

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Iowa City IA, Madison WI, Kansas City MO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

The Heartland Study

for
Pregnancy Related, Pregnancy Complications, Birth Defect,
Location: Iowa City IA, Marshfield WI, Indianapolis IN
Sponsor: Heartland Health Research Alliance

Sex: Female

Age: 18+

Code: NCT05492708

Recruiting
Active & Responsive

Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study

for
Rotator Cuff Tears
Location: Iowa City IA, Ann Arbor MI, Dallas TX
Sponsor: University of Michigan

Sex: All

Age: 40 - 70+

Code: NCT04831164

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

for
NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis
Location: Iowa City IA, Rochester MN, Milwaukee WI, Cleveland OH,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 12+

Code: NCT05503264

Phase3, Recruiting
Active & Responsive

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

for
Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1,
Location: Iowa City IA
Sponsor: University of Iowa

Sex: All

Age: 18+

Code: NCT06395402

Phase2, Recruiting
Active & Responsive

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

for
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma,
Location: Iowa City IA, Chicago IL, Milwaukee WI, Detroit MI,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05950464

Phase1, Recruiting